Life-Threatening Myelosuppression in Patients with Occult Renal Impairment Receiving Topotecan
Open Access
- 31 December 1997
- journal article
- editorial
- Published by Elsevier in Gynecologic Oncology
- Vol. 67 (3) , 329-330
- https://doi.org/10.1006/gyno.1997.4896
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer.Journal of Clinical Oncology, 1997
- Phase I and pharmacologic study of topotecan in patients with impaired renal function.Journal of Clinical Oncology, 1996
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976
- Creatinine Clearance: Bedside EstimateAnnals of Internal Medicine, 1973